0020

Da An Gene Co., Ltd. of Sun Yat-Sen University (002030)

Market Closed
10 Mar, 06:57
XSHE XSHE
¥
6. 52
0
0%
¥
8.76B Market Cap
35.97 P/E Ratio
0.07% Div Yield
42,682,619 Volume
0.74 Eps
¥ 6.52
Previous Close
Day Range
6.5 6.82
Year Range
4.71 8.96
Earnings results expected in 38 days

Summary

002030 closed yesterday higher at ¥6.52, an increase of 0% from Friday's close, completing a monthly increase of 22.56% or ¥1.2. Over the past 12 months, 002030 stock gained 14.79%.
002030 is not paying dividends to its shareholders.
The last earnings report, released on Oct 30, 2024, missed the consensus estimates by -0.07%. On average, the company has fell short of earnings expectations by -0.12%, based on the last three reports. The next scheduled earnings report is due on Apr 18, 2025.
Da An Gene Co., Ltd. of Sun Yat-Sen University has completed 2 stock splits, with the recent split occurring on May 19, 2021.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSHE (CNY).
Want to track 002030 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

002030 Chart

Da An Gene Co., Ltd. of Sun Yat-Sen University (002030) FAQ

What is the stock price today?

The current price is ¥6.52.

On which exchange is it traded?

Da An Gene Co., Ltd. of Sun Yat-Sen University is listed on XSHE.

What is its stock symbol?

The ticker symbol is 002030.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 8.76B.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Apr 18, 2025.

Has Da An Gene Co., Ltd. of Sun Yat-Sen University ever had a stock split?

Da An Gene Co., Ltd. of Sun Yat-Sen University had 2 splits and the recent split was on May 19, 2021.

Da An Gene Co., Ltd. of Sun Yat-Sen University Profile

Biotechnology Industry
Healthcare Sector
Ms. Luo Huang CEO
XSHE Exchange
CNE000001KP1 ISIN
CN Country
1,968 Employees
- Last Dividend
19 May 2021 Last Split
23 Jul 2004 IPO Date
Daan Gene Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells clinical test reagents, instruments, and supporting consumables in China. It operates through Biological Products and Related Business and Financial Business segments. The company offers reagents for hepatitis virus, sexually transmitted infections, blood screening, digestive pathogens, coronavirus disease (COVID-19), pharmacogenomics, viral transport medium, human papillomavirus, human immunodeficiency virus, respiratory infections, public health, tumor maker, and nucleic acid extraction, as well as polymerase chain reaction, sample preparation, and nucleic extraction systems for molecular diagnosis; COVID-19 rapid test kit and chemiluminescence immunoassay analyzers for immunoassay; liquid based cytology production and automatic sample transfer machines for pathology tests; and auto biochemistry analyzers and chemistry reagents for clinical chemistry. It also provides medical laboratory and health consultation services, such as genetic susceptibility gene testing, tumor marker testing, cervical cancer screening, routine physical examination, and other health services. The company sells its products under the Daan Gene, Darui Biology, LBP, and Zhongshan Bio-Tech brands. In addition, it is involved in biological technology, biomedicine and biopharmaceutical, clinical test, business, software development, trading, hospital investment management, capital market, insurance agent, management, finance lease, microfinance, commercial factoring, loan, consulting, and technology promotion and application service industry services. The company was formerly known as Da An Gene Co., Ltd. of Sun Yat-Sen University. Daan Gene Co., Ltd. was founded in 1988 and is headquartered in Guangzhou, China.

Contact Information

Address: No.19, Xiangshan Road, Guangzhou, China, 510665
Phone: 86 20 3229 0789